- Home
- LAB vs SLRN Comparison
LAB vs SLRN Comparison
Compare LAB & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- SLRN
- Stock Information
- Founded
- LAB 1999
- SLRN 2020
- Country
- LAB United States
- SLRN United States
- Employees
- LAB N/A
- SLRN N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- LAB Industrials
- SLRN Health Care
- Exchange
- LAB Nasdaq
- SLRN Nasdaq
- Market Cap
- LAB 562.1M
- SLRN 485.6M
- IPO Year
- LAB 2011
- SLRN 2023
- Fundamental
- Price
- LAB $2.21
- SLRN $3.50
- Analyst Decision
- LAB Strong Buy
- SLRN Buy
- Analyst Count
- LAB 2
- SLRN 4
- Target Price
- LAB $2.88
- SLRN $11.75
- AVG Volume (30 Days)
- LAB 1.6M
- SLRN 708.4K
- Earning Date
- LAB 10-30-2024
- SLRN 11-13-2024
- Dividend Yield
- LAB N/A
- SLRN N/A
- EPS Growth
- LAB N/A
- SLRN N/A
- EPS
- LAB N/A
- SLRN N/A
- Revenue
- LAB $155,902,000.00
- SLRN N/A
- Revenue This Year
- LAB $62.60
- SLRN N/A
- Revenue Next Year
- LAB $9.91
- SLRN N/A
- P/E Ratio
- LAB N/A
- SLRN N/A
- Revenue Growth
- LAB 48.23
- SLRN N/A
- 52 Week Low
- LAB $1.21
- SLRN $3.14
- 52 Week High
- LAB $3.04
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- LAB 65.48
- SLRN 31.38
- Support Level
- LAB $1.82
- SLRN $3.18
- Resistance Level
- LAB $2.07
- SLRN $4.47
- Average True Range (ATR)
- LAB 0.15
- SLRN 0.29
- MACD
- LAB 0.04
- SLRN -0.07
- Stochastic Oscillator
- LAB 92.45
- SLRN 20.34
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.